BCDA BIOCARDIA INC revenue, earnings and financials
For the quarter ended June 30, 2026, BIOCARDIA INC reported revenue of n/a, net income of −$1.61M and diluted EPS of n/a; for the fiscal year ended December 2025 revenue was $0, down 100.0% on the year before.
BCDA annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $0, gross profit n/a, operating income −$8.28M, net income −$8.23M (margin n/a), EPS n/a
- Fiscal year ended Dec 2024: revenue $58.0K, gross profit n/a, operating income −$8.00M, net income −$7.95M (margin -13700.0%), EPS n/a
- Fiscal year ended Dec 2023: revenue $477K, gross profit n/a, operating income −$11.6M, net income −$11.6M (margin -2425.8%), EPS n/a
- Fiscal year ended Dec 2022: revenue $1.35M, gross profit n/a, operating income −$11.9M, net income −$11.9M (margin -880.7%), EPS n/a
- Fiscal year ended Dec 2021: revenue $1.02M, gross profit n/a, operating income −$12.6M, net income −$12.6M (margin -1243.6%), EPS −$0.75
BCDA quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$1.61M, EPS n/a
- Quarter ended Mar 31, 2026: revenue n/a, net income −$2.26M, EPS −$0.21
- Quarter ended Dec 31, 2025 (from the annual report): revenue $0, net income −$1.98M, EPS n/a
- Quarter ended Sep 30, 2025: revenue $0, net income −$1.48M, EPS n/a
- Quarter ended Jun 30, 2025: revenue $0 (down 100.0% year over year), net income −$2.05M, EPS −$0.40
- Quarter ended Mar 31, 2025: revenue $0 (down 100.0% year over year), net income −$2.71M, EPS −$0.59
- Quarter ended Dec 31, 2024 (from the annual report): revenue $0 (down 100.0% year over year), net income −$2.30M, EPS n/a
- Quarter ended Sep 30, 2024: revenue $0 (down 100.0% year over year), net income −$1.74M, EPS n/a
- Quarter ended Jun 30, 2024: revenue $3.00K (down 93.0% year over year), net income −$1.65M, EPS n/a
- Quarter ended Mar 31, 2024: revenue $55.0K (down 14.1% year over year), net income −$2.27M, EPS n/a
- Quarter ended Dec 31, 2023 (from the annual report): revenue $13.0K (down 87.7% year over year), net income −$2.07M, EPS n/a
- Quarter ended Sep 30, 2023: revenue $357K (up 68.4% year over year), net income −$2.57M, EPS n/a
- Quarter ended Jun 30, 2023: revenue $43.0K (down 95.6% year over year), net income −$3.42M, EPS n/a
- Quarter ended Mar 31, 2023: revenue $64.0K (up 6.7% year over year), net income −$3.50M, EPS n/a
- Quarter ended Dec 31, 2022 (from the annual report): revenue $106K (up 34.2% year over year), net income −$3.03M, EPS n/a
- Quarter ended Sep 30, 2022: revenue $212K (down 74.2% year over year), net income −$3.06M, EPS n/a
- Quarter ended Jun 30, 2022: revenue $974K (up 1311.6% year over year), net income −$2.50M, EPS n/a
- Quarter ended Mar 31, 2022: revenue $60.0K (up 30.4% year over year), net income −$3.33M, EPS n/a
- Quarter ended Dec 31, 2021 (from the annual report): revenue $79.0K, net income −$3.46M, EPS −$0.21
- Quarter ended Sep 30, 2021: revenue $821K, net income −$2.71M, EPS −$0.16
BCDA cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$7.44M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$7.89M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$9.97M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$10.6M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$10.4M, share buybacks n/a
BCDA balance sheet
- Jun 30, 2026: cash $4.12M, total assets $4.76M, total liabilities $2.06M, shareholders' equity $2.70M
- Mar 31, 2026: cash $951K, total assets $1.71M, total liabilities $2.78M, shareholders' equity −$1.07M
- Dec 31, 2025: cash $2.50M, total assets $3.41M, total liabilities $2.52M, shareholders' equity $895K
- Sep 30, 2025: cash $5.29M, total assets $6.15M, total liabilities $3.52M, shareholders' equity $2.63M
- Jun 30, 2025: cash $980K, total assets $2.09M, total liabilities $3.98M, shareholders' equity −$1.89M
- Mar 31, 2025: cash $949K, total assets $2.17M, total liabilities $3.69M, shareholders' equity −$1.52M
- Dec 31, 2024: cash $2.37M, total assets $3.72M, total liabilities $2.89M, shareholders' equity $837K
- Sep 30, 2024: cash $4.93M, total assets $6.27M, total liabilities $3.51M, shareholders' equity $2.75M
What is BCDA's revenue?
BIOCARDIA INC reported $0 of revenue for the fiscal year ended December 2025.
Is BCDA profitable?
No. BIOCARDIA INC lost $7.34M over the last four quarters.